公开(公告)号：EP2770985A1

公开(公告)日：2014-09-03

申请号：EP12844536.8

申请日：2012-10-25

申请人： U.S. Phytotherapy Inc. ,  Rosen, Bob ,  Muehler, Andreas ,  Mintorovitch, Jan ,  Arora, Karan ,  Perez, David ,  Perez, Nicholas Ari ,  Choksi, Tejas D.

发明人： ROSEN, Bob ,  MUEHLER, Andreas ,  MINTOROVITCH, Jan ,  ARORA, Karan ,  PEREZ, David ,  PEREZ, Nicholas Ari ,  CHOKSI, Tejas D.

IPC分类号： A61K9/20 ,  A61K9/48 ,  A61K31/335 ,  A61K31/435 ,  A61P33/06

CPC分类号： A61K9/2054 ,  A61K9/0056 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2059 ,  A61K9/288 ,  A61K31/365 ,  A61K31/366 ,  A61K31/4375 ,  A61K31/4741 ,  A61K31/4745 ,  B65B1/00 ,  Y02A50/385 ,  Y02A50/387 ,  Y02A50/401 ,  Y02A50/411 ,  Y02A50/475 ,  A61K2300/00

摘要： An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.